Table 1.
Baseline Characteristics
COMPLETERS | ALL | |||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
MBCT | SD | CON | SD | MBCT | SD | CON | SD | |
N | 14 | 10 | 15 | 11 | ||||
% female | 78.5 | 90.0 | 80.0 | 81.8 | ||||
Age | 47.7 | 8.0 | 45.1 | 14.2 | 47.9 | 7.8 | 45.7 | 8.0 |
BDI | 8.3 | 5.9 | 11.8 | 7.3 | 8.2 | 5.7 | 10.8 | 7.6 |
HRSD | 9.9 | 7.4 | 11.8 | 6.7 | 9.6 | 7.2 | 10.7 | 7.3 |
dep months | 57.5 | 38.0 | 57.8 | 36.3 | 58.6 | 36.9 | 64.0 | 40.1 |
% in remission | 50.0 | 60.0 | 46.7 | 54.5 | ||||
% SSRIs | 71.0 | 70.0 | 73.0 | 73.0 | ||||
% completers | 93.3 | 90.9 |
Note: BDI= Beck Depression Inventory; HRSD= Hamilton Rating Scale for Depression; dep months= total number of months of previous depression across all episodes; remission=BDI score<10;
According to independent sample t-tests for the whole sample and completers, there were no significant differences between treatment groups in age, BDI scores or months of previous depression. Similarly, there were no differences in % female, % in remission or % completers, according to Fisher’s Exact Test.